Heart Failure Drugs Market Economic Impact, Dynamics and SWOT Analysis Till 2030

 

Heart Failure Drugs Market Overview

Market Research Future (MRFR) believes that the heart failure drugs market can record a decent growth rate of 5.9% between 2022 and 2030 (appraisal period). It is also projected that the market size can touch USD 18.10 Billion by 2030.

People more than 60 years of age are the major patient pool in the global market. The demographic is marked by reduced immunity levels and are therefore vulnerable to chronic ailments including heart failure. Therefore, the consistent expansion of the geriatric population worldwide will be a significant growth booster in the Heart Failure Drugs Market over the ensuing years.

The Centers for Disease Control and Prevention reveals that nearly 5.7 million people in the US suffer from heart failure. The condition is marked by the heart’s inability to pump sufficient blood as well as oxygen that are required for supporting all the other organs in the human body. It is a serious disorder, although the heart continues to beat. But past reports show that more than half of the patients that developed heart failure die within 6 years of being diagnosed.

Heart failure has emerged as one of the most lethal health conditions in the world and affects patients that lead unhealthy lifestyle and face poor prognosis. Risk factors are hypertension, obesity and diabetes, all of which have been witnessing a surge in the global current population. Unmet medical needs are quite high, especially in emerging regions, and the demand for reduced mortality should elevate the need for more drugs in the global market. Growing number of approvals as well as launch of the ACE inhibitors and the robustness of the latest pipeline can also enhance the market share in the coming years.

Heart Failure Drugs Market Segmentation

The key segments highlighted in the MRFR study of the Heart Failure Drugs industry include type and end-user.

The global market, depending on type, caters to ACE Inhibitors, Diuretic, Beta-Blockers, Angiotensin Receptor Blockers (ARBs), Angiotensin-Receptor Neprilysin Inhibitors (ARNI), and others. ACE inhibitors are the most extensively prescribed types of drugs, as these play an essential role in managing heart failure. These relax the blood vessels and bring down the blood pressure, thereby facilitating smooth blood flow.

The global heart failure drugs market, by end-user, has been categorized as hospitals, specialty centers, and others. Hospital segment has procured the leading position in the global industry, on account of their soaring number worldwide and medications increasingly being prescribed at these institutions.

Heart Failure Drugs Market Regional Analysis

The market for heart failure drugs has been regionally segregated into Asia Pacific/APAC, Americas, MEA or Middle East & Africa and Europe.

Americas has taken the prime spot in the global market since the region generates significant demand for heart failure drugs in view of the escalating cases of cardiovascular disorder. High healthcare spending along with the surge in obesity cases also add to the market value. Besides, the growing prevalence of unhealthy lifestyle including high alcohol intake, bad diet, smoking, and lack of exercise has raised people’s vulnerability to arrhythmia as well as heart failure. This is bound to create a favorable scenario for the regional market in the following years.

Europe is the second most lucrative market for heart failure drugs and will continue to record a considerable growth rate in the ensuing years. The soaring incidences of cardiovascular diseases along with the burgeoning population of smokers has amplified the market growth rate in the region. Moreover, the expanding elderly populace in the European Union should also benefit the regional market over the analysis period.

Asia Pacific is emerging as one of the strongest markets, thanks to the blossoming patient pool along with the surge in technological advances in healthcare. The market’s rapid growth is also the result of the rise in per capita income as well as government initiatives aimed at improving the healthcare infrastructure.

Major Firms

Merck Sharp & Dohme Corp. (U.S.), AstraZeneca (U.K.), Novartis AG (Switzerland), Gilead Sciences, Inc. (California), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Boehringer Ingelheim International GmbH (Germany), Pfizer, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.K.), are the prominent firms in the global market for heart failure drugs market Players

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

 

 

 


Comments

Post a Comment

Popular posts from this blog

Chronic Obstructive Pulmonary Disease Treatment Market Trends, Overview, Competitors Strategy, Regional Analysis and Growth Foresight 2030

Image
  Chronic Obstructive Pulmonary Disease Treatment Market Overview The global market report on chronic obstructive pulmonary disease has the potential to capitalize on various factors that have a link with unhealthy lifestyle or pollution and others. Due to this unhealthy lifestyle, many people have started smoking, which can directly influence various chronic obstructive pulmonary diseases. On the other hand, if people spend their time in places with poor airflow, they can trigger various symptoms of the disease. Pollution can alleviate the symptoms and play a significant role in influencing the increase in number for people suffering from the disease. with the increasing factors like pollution and other unhealthy lifestyles. These factors have been noted by Market Research Future (MRFR) for their elaborate study on the same market.  The Chronic Obstructive Pulmonary Disease Market  Size was valued at USD 1.82 billion in 2021 and is projected to grow from USD 3.07 Billi...
Read more

Dental 3D Printing Market Trend, Size, Growth and Forecast to 2030

Image
  Dental 3D Printing Market Overview Dental 3D printing witnesses extensive demand in the cosmetic dentistry which in turn, escalates its market on the global heights. Considering the kind of the growth, the market perceives currently, Market Research Future (MRFR) in its recently published analysis asserts that the global  Dental 3D Printing Market   will register over 15.61 % CAGR during the review period (2022 – 2030), reaching exponential heights by 2030.  Dental 3D printing is a huge evolution that ever occurred in the dental world. It can perform faster, is cost-competitive, and can offer unique products and services, providing an excellent return on investment. Considered as the form of modern dentistry, dental 3D printing creates three dimensional solid dental models for surgical guides, dentures, dental implants, crown, and bridges. Additional factors substantiating the market growth include the growing prevalence of dental decays and diseases and increa...
Read more

RSV Diagnostics Market Segments, Industry Sales, Profits and Regional Study 2030

Image
  RSV Diagnostics Market Overview The rising incidence rate of respiratory infections has done wonders for the market and is bound to surge at a significant rate in the coming years. with the growth in the incidences of chronic diseases around the world, there is bound to be an increase in the case of respiratory infections. This is going to have a definite positive impact on the demand for testing of infectious diseases like RSV. The deaths among neonates owing to these infections can be prevented when timely diagnosis and subsequent treatment is provided. Thus, the growing awareness regarding this factor is set to enhance the growth of the  RSV Diagnostics Market   in the years ahead. The latest report by Market Research Future (MRFR) states that the Respiratory Syncytial Virus (RSV) market is all set to gain substantial traction by accruing gigantic revenues by 2030. In addition, it is on track to surge at a CAGR of 10.7 % during the forecast period (2022–2030).The d...
Read more